Sundari Ravindran
Overview
Explore the profile of Sundari Ravindran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferguson L, Fried S, Matsaseng T, Ravindran S, Gruskin S
BMJ
. 2019 May;
365:l1941.
PMID: 31085551
No abstract available.
2.
Tsai V, Varghese R, Ravindran S, Ralston R, Vellekamp G
Viral Immunol
. 2009 Jan;
21(4):469-76.
PMID: 19115936
Realization of the potential clinical utility of recombinant adenovirus for gene therapy or vaccine development depends on a better understanding of the role of naturally occurring or therapy-induced anti-adenovirus antibodies....
3.
Yang X, Agarwala S, Ravindran S, Vellekamp G
J Pharm Sci
. 2007 Jun;
97(2):746-63.
PMID: 17593554
Recombinant adenoviruses (rAd), widely used as vectors for gene therapy, are generally purified by column chromatography and frequently contain empty capsids and other aberrant forms of virus particles. To determine...
4.
Lee S, Ravindran S, Vellekamp G
Hum Gene Ther
. 2007 Mar;
18(3):286-300.
PMID: 17378767
As with certain successful protein drug treatments, the attachment of polyethylene glycol (PEG) molecules to recombinant adenovirus (rAd) can augment their therapeutic potential. Unlike these proteins, the rAd particle has...
5.
Machemer T, Engler H, Tsai V, Lee S, Cannon-Carlson S, Voloch M, et al.
Mol Ther
. 2005 Jul;
12(2):254-63.
PMID: 16043097
Intravascular administration of recombinant adenovirus (rAd) in cancer patients has been well tolerated. However, dose-limiting hemodynamic responses associated with suppression of cardiac output have been observed at doses of 7.5...
6.
Sutjipto S, Ravindran S, Cornell D, Liu Y, Horn M, Schluep T, et al.
Hum Gene Ther
. 2005 Feb;
16(1):109-25.
PMID: 15703494
As virus vectors for gene therapy approach the goal of successful clinical treatment, it is increasingly necessary for the product to be fully characterized. Empty capsids are perhaps the main...